vimarsana.com

Page 3 - எங்களுக்கு துறை ஆஃப் வர்த்தகம் பணியகம் தொழில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

US Blacklists Seven Chinese Supercomputer Organisations

US Blacklists Seven Chinese Supercomputer Organisations The US Department of Commerce’s Bureau of Industry and Security (BIS) has added seven Chinese supercomputing organisations to the Entity List which bars them from conducting activities with US companies without first obtaining a US government license. These are organisations considered  to be contrary to the national security or foreign policy interests of the United States.   The companies added to the  list are involved either with building supercomputers used by China’s military actors, its military modernisation efforts or weapons of mass destruction. US officials have long complained that Chinese companies are under the direction of the People’s Republic of China and collect sensitive information on behalf of the People’s Liberation Army. It is the first move by the Biden administration to make it harder for China to obtain US technology. “Supercomputing capabilities are vital for the development of

With Phytium on US entity list, Alchip halts its orders

With Phytium on US entity list, Alchip halts its orders By Lisa Wang / Staff reporter Alchip Technologies (世芯), which designs application-specific ICs (ASICs) for other companies, yesterday said that it has halted shipments to Chinese semiconductor company Phytium Information Technology Co (飛騰信息技術), which could lower its revenue this year by as much as 25 percent. Alchip said that it has put on hold all production activity originally planned for Phytium after the Chinese chip company was put onto the entity list of the US Department of Commerce’s Bureau of Industry and Security on Thursday last week, along with six other Chinese companies.

Transatlantic Trade US and Europe – April 5, 2021

COVID-19 Updates | EU, UK, US The AstraZeneca COVID-19 vaccine, recently renamed Vaxzevria, made headlines this week in Europe, due to rising concerns over the links with its use and the development of blood clots.  The European Medicines Agency (EMA) again reviewed the data on the reported cases and published another opinion on 7 April 2021, confirming there is a potential link with “very rare cases of unusual blood clots with low blood platelets”.  While the EMA’s safety committee recognized that some of the blood clots cases are linked to the vaccine, it stressed,  “[T]he overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects”.  The EMA confirmed that unusual blood clots should be listed as a very rare side effect, but considering the benefits of the vaccine overall, it remains approved in the EU for people above 18 years old.

Chinese Supercomputing Companies on US Commerce s Entity List

Legal Disclaimer You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Huawei ban timeline: Company reports 2020 revenue growth in China, declines elsewhere

Huawei ban timeline: Company reports 2020 revenue growth in China, declines elsewhere
cnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.